U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129 books (198 items)

1.
Primary End-points for Prophylactic HPV Vaccine Trials.

Primary End-points for Prophylactic HPV Vaccine Trials.

IARC HPV Working Group.

Lyon (FR): International Agency for Research on Cancer; 2014. (IARC Working Group Reports, No. 7.)

2.
3.
Malaria and Some Polyomaviruses (SV40, BK, JC, and Merkel Cell Viruses).

Malaria and Some Polyomaviruses (SV40, BK, JC, and Merkel Cell Viruses).

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2013. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 104.)

4.
Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines.

Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines.

National Academy of Medicine;National Academies of Sciences, Engineering, and Medicine;Health and Medicine Division;Board on Global Health;Committee on Addressing Issues of Vaccine Distribution and Supply Chains to Advance Pandemic and Seasonal Influenza Preparedness and Response; Ashby E, Jefferson KMP, Yadav P, et al., editors.

Washington (DC): National Academies Press (US); 2021 Nov 17.

5.
Emerging Viral Diseases: The One Health Connection: Workshop Summary.

Emerging Viral Diseases: The One Health Connection: Workshop Summary.

Forum on Microbial Threats; Board on Global Health; Institute of Medicine.

Washington (DC): National Academies Press (US); 2015 Mar 19.

6.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

7.
8.
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis.

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis.

Arvin A, Campadelli-Fiume G, Mocarski E, et al., editors.

Cambridge: Cambridge University Press; 2007.

9.
Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses.

Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1996. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 67.)

10.
Global Health Impacts of Vector-Borne Diseases: Workshop Summary.

Global Health Impacts of Vector-Borne Diseases: Workshop Summary.

Forum on Microbial Threats; Board on Global Health; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine.

Washington (DC): National Academies Press (US); 2016 Sep 21.

11.
Adverse Effects of Vaccines: Evidence and Causality.

Adverse Effects of Vaccines: Evidence and Causality.

Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al., editors.

Washington (DC): National Academies Press (US); 2011 Aug 25.

12.
Safety of Vaccines Used for Routine Immunization in the United States: An Update [Internet].

Safety of Vaccines Used for Routine Immunization in the United States: An Update [Internet].

Gidengil C, Goetz MB, Maglione M, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. (Comparative Effectiveness Review, No. 244.)

13.
Retroviruses.

Retroviruses.

Coffin JM, Hughes SH, Varmus HE, editors.

Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997.

14.
Emerging Technologies for Nutrition Research: Potential for Assessing Military Performance Capability.

Emerging Technologies for Nutrition Research: Potential for Assessing Military Performance Capability.

Institute of Medicine (US) Committee on Military Nutrition Research; Carlson-Newberry SJ, Costello RB, editors.

Washington (DC): National Academies Press (US); 1997.

15.
Biological Agents.

Biological Agents.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2012. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100B.)

16.
Human Papillomaviruses.

Human Papillomaviruses.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 90.)

17.
Indo-U.S. Workshop on Challenges of Emerging Infections and Global Health Safety: Summary of a Workshop.

Indo-U.S. Workshop on Challenges of Emerging Infections and Global Health Safety: Summary of a Workshop.

Committee on India-United States Cooperation on Challenges of Emerging Infections and Global Health Safety; Policy and Global Affairs; National Academy of Sciences; Indian National Science Academy.

Washington (DC): National Academies Press (US); 2016 May 6.

18.
Hepatitis Viruses.

Hepatitis Viruses.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1994. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 59.)

19.
Innovations in Pharmaceutical Manufacturing on the Horizon: Technical Challenges, Regulatory Issues, and Recommendations.

Innovations in Pharmaceutical Manufacturing on the Horizon: Technical Challenges, Regulatory Issues, and Recommendations.

National Academies of Sciences, Engineering, and Medicine; Division on Earth and Life Studies; Board on Chemical Sciences and Technology; Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing.

Washington (DC): National Academies Press (US); 2021 Feb 24.

20.
Principles and Practice of Emergency Research Response [Internet].

Principles and Practice of Emergency Research Response [Internet].

Sorenson RA, Higgs ES, Fallah MP, et al., editors.

Cham (CH): Springer; 2024.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...